Solo Brands Announces Leadership Change to Support Its Next Chapter of Growth
Updates 2023 Full-Year Sales and EBITDA Guidance Appoints Christopher T. Metz as President and Chief Executive Officer GRAPEVINE, Texas–(BUSINESS WIRE)–Solo... Read more.
OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2023 Revenue and EBITDA in line with Guidance and Introduces Fiscal 2024 Revenue and EBITDA Guidance
Company to Present at the ICR Conference Today, January 8, 2024 NASSAU, Bahamas–(BUSINESS WIRE)–OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent... Read more.
J.Jill, Inc. Reaffirms Fourth Quarter and Full Year 2023 Guidance Ahead of the 26th Annual ICR Conference
QUINCY, Mass.–(BUSINESS WIRE)–J.Jill, Inc. (NYSE:JILL) today reaffirmed its fourth quarter and full year 2023 guidance in advance of its presentation... Read more.
Spire Global Awarded $9.4 Million Contract by NOAA for Satellite Weather Data
Radio occultation data collected by the Company’s satellite constellation improves the accuracy of global weather forecasts VIENNA, Va.–(BUSINESS WIRE)–Spire... Read more.
US Foods Reaffirms Fiscal Year 2023 Guidance; Company to Participate at the 2024 ICR Conference
ROSEMONT, Ill.–(BUSINESS WIRE)–US Foods Holding Corp. (NYSE: USFD) announced today that it is reaffirming its fiscal year 2023 guidance introduced on... Read more.
Domain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company
Michael Gottlieb appointed as Chairman of the Board of Directors Dr. Anthony Johnson appointed as President and Chief Executive Officer STRASBOURG, France &... Read more.
Air Lease Corporation Announces Fourth Quarter and Year End 2023 Earnings Conference Call
LOS ANGELES–(BUSINESS WIRE)–Air Lease Corporation (NYSE: AL) will host a conference call on February 15, 2024 at 4:30 PM Eastern Time to discuss the... Read more.
Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference
Excitement over December 2023 launch of ZURZUVAE™ (zuranolone), the first and only oral treatment indicated for adults with postpartum depression (PPD) Continued... Read more.
Enpro Inc. to Appoint Joseph F. Bruderek Jr. as Chief Financial Officer
CHARLOTTE, N.C.–(BUSINESS WIRE)–Enpro Inc. (NYSE: NPO), an industrial technology company, today announced that Joe Bruderek has joined the company as... Read more.
Tilly’s, Inc. Announces 2023 Holiday Period Net Sales, Updates Fourth Quarter Outlook
IRVINE, Calif.–(BUSINESS WIRE)–Tilly’s, Inc. (NYSE: TLYS, the “Company”) today announced net sales results for the nine-week period ended December... Read more.